Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune status against tetanus; and EBX molecular biology range, which includes a range of tests for identifying various pathogens responsible for infectious diseases. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Metrics to compare | ALERS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALERSPeersSector | |
---|---|---|---|---|
P/E Ratio | 105.7x | −2.8x | −0.7x | |
PEG Ratio | −1.69 | 0.11 | 0.00 | |
Price/Book | 1.4x | 1.4x | 2.6x | |
Price / LTM Sales | 1.5x | 9.4x | 3.4x | |
Upside (Analyst Target) | 21.2% | 156.9% | 37.7% | |
Fair Value Upside | Unlock | 10.1% | 4.1% | Unlock |